Free Trial
NASDAQ:DMAAU

Drugs Made in America Acquisition (DMAAU) Stock Price, News & Analysis

Drugs Made in America Acquisition logo
$10.50 +0.06 (+0.57%)
As of 07/24/2025 09:30 AM Eastern

About Drugs Made in America Acquisition Stock (NASDAQ:DMAAU)

Key Stats

Today's Range
$10.50
$10.50
50-Day Range
$10.25
$10.50
52-Week Range
$10.00
$10.82
Volume
2,405 shs
Average Volume
42,042 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DMAAU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Drugs Made in America Acquisition and its competitors with MarketBeat's FREE daily newsletter.

DMAAU Stock News Headlines

DMAAU Drugs Made In America Acquisition Corp. Units
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
DMAA Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp
See More Headlines

DMAAU Stock Analysis - Frequently Asked Questions

Drugs Made in America Acquisition's stock was trading at $10.00 at the start of the year. Since then, DMAAU stock has increased by 5.0% and is now trading at $10.50.

Drugs Made in America Acquisition (DMAAU) raised $200 million in an initial public offering on Tuesday, January 28th 2025. The company issued 20,000,000 shares at $10.00 per share. Clear Street served as the underwriter for the IPO.

Drugs Made in America Acquisition's lock-up period expires on Monday, July 28th. Drugs Made in America Acquisition had issued 20,000,000 shares in its public offering on January 28th. The total size of the offering was $200,000,000 based on an initial share price of $10.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

Shares of DMAAU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Investment Offices
Sub-Industry
Trading
Current Symbol
NASDAQ:DMAAU
CIK
2028614
Web
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
N/A
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:DMAAU) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners